Antitumoral and antiangiogenic activity of Synadenium umbellatum Pax

Journal of Ethnopharmacology

Volumn 120, Issue 3, 2008, Pages 474-478

  Nogueira, Iara Antonia L ^a   Leão, Aryane B B ^a   Vieira, Marcelo de S ^a   Benfica, Polyana L ^a   da Cunha, Luiz Carlos ^a   Valadares, Marize C ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Antitumoral activity; Ehrlich ascites tumor; Euphorbiaceae; Synadenium umbellatum Pax

Indexed keywords

METHOTREXATE; PLANT EXTRACT; SYNADENIUM UMBELLATUM EXTRACT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL STRAIN K 562; CONTROLLED STUDY; DRUG DOSE COMPARISON; EHRLICH ASCITES TUMOR; HUMAN; HUMAN CELL; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; SYNADENIUM UMBELLATUM; TUMOR XENOGRAFT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; BRAZIL; CARCINOMA, EHRLICH TUMOR; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EUPHORBIACEAE; HUMANS; K562 CELLS; LEUKEMIA; MALE; MEDICINE, TRADITIONAL; MICE; PHYTOTHERAPY; PLANT EXTRACTS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; EUPHORBIACEAE; MUS; SYNADENIUM;

EID: 56349135887     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.08.026     Document Type: Article

References (27)

1. Ajith T.A., and Janardhanan K.K. Cytotoxic and antitumor activities of a polypore macrofungus, Phellinus rimosus (Berk.) Pilat. Journal of Ethnopharmacology 84 (2003) 157-162
2. Bagalkotkar G., Sagineedu S.R., Saad M.S., and Stanslas J. Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties-a review. The Journal of Pharmacy and Pharmacology 8 (2006) 1559-1570
3. Baka S., Clamp A.R., and Jayson G.C. A review of the latest clinical compounds to inhibit VEGF in pathological angiogenesis. Expert Opinion on Therapeutic Targets 10 (2006) 867-876
4. Baloch I.B., Baloch M.K., and Saqib Q.N. Anti-tumor 12-deoxyphorbol esters from Euphorbia cornigera. European Journal of Medicinal Chemistry 43 (2008) 274-281
5. CCAC (Canadian Council on Animal Care). Guide to the Care and Use of Experimental Animals. 2nd edition vol. 1 (1993)
6. Detmar M. Symposium Proceedings on Tumor Angiogenesis. The Journal of Investigative Dermatology 5 (2000) 20-23
7. Dun, D., Singh, B.S.M.P., 2007. The family Euphorbiacea in India: a synopsis of its profile, taxonomy and bibliography/N.P. Balakrishnan, T. Chakrabarty, p. 500.
8. Dvorak H.F. Angiogenesis. Journal Thrombosis Haemostasis 3 (2005) 1835-1842 Update 2005
9. Ferreira M.A., Barcelos L.S., Teixeira M.M., Bakhle Y.S., and Andrade S.P. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF). Life Sciences 81 (2007) 210-217
10. Jassbi A.R. Chemistry and biological activity of secondary metabolites in Euphorbia from Iran. Phytochemistry 67 (2006) 1977-1984
11. Kessler T., Fehrmann F., Bieker R., Berdel W.E., and Mesters R.M. Vascular endothelial growth factor and its receptor as drug targets in hematological malignancies. Current Drug Targets 8 (2007) 257-268
12. Luo H., and Wang A. Induction of apoptosis in K-562 cells by jolkinolide B. Canadian Journal of Physiology Pharmacology 84 (2006) 959-965
13. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunology Methods 65 (1983) 55-63
14. Ortêncio W.B. Medicina popular do Centro-Oeste. 2nd edition (1997), Thesaurus, Brasília p. 322
15. Petersen I. Antiangiogenesis, anti-VEGF(R) and outlook. Recent Results in Cancer Research 176 (2007) 189-199
16. Premaratna A., Shadaksharaswamy M., and Nanjappa S. Isolation, purification & properties of a lectin from the latex of Synadenium grantii Hook f. Indian Journal of Biochemistry and Biophysics 18 (1981) 32-35
17. Rajesh R., et al. Purification and characterization of 34-kDa, heat stable glycoprotein from Synadenium grantii latex: action on human fibrinogen and fibrin clot. Biochimie 88 (2006) 1313-1322
18. Ribatti D., Vacca A., Nico B., Sansonno D., and Dammacco F. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma. Cancer Treatment Reviews 32 (2006) 437-444
19. Rogerio A.P., et al. Anti-asthmatic potential of a d-galactose-binding lectin from Synadenium carinatum latex. Glycobiology 17 (2007) 795-804
20. Shibuya M., Luo J.C., Toyoda M., and Yamaguchi S. Involvement of VEGF and its receptors in ascites tumor formation. Cancer Chemotherapy and Pharmacology 43 (1999) S72-S77
21. Souza M.A., et al. Isolation and partial characterization of d-galactose-binding lectin from the latex Synadenium carinatum. Brazilian Archives of Biology and Technology 48 (2005) 705-716
22. Stoelcker B., Echtenacher B., Weich H.A., Sztajer H., Hicklin D.J., and Mannel D.N. EGF/Flk-1 interaction, a requirement for malignant ascites recurrence. Journal of Interferon and Cytokine Research 20 (2000) 511-517
23. Tanaka R., Wada S., Yamada T., and Yamori T. Potent antitumor activity of 3,4-seco-8betaH-Ferna-4(23),9(11)-dien-3-oic acid (EC-2) and 3,4-seco-Oleana-4(23),18-dien-3-oic acid (EC-4), evaluated by an in vitro human cancer cell line panel. Planta Medica 72 (2006) 1347-1349
24. Teixeira A.S., Araújo F.A., Ferreira M.A., Barcelos L.S., Teixeira M.M., and Andrade S.P. Angiogenesis and inflammation in skeletal muscle in response to ascites tumor in mice. Life Sciences 78 (2006) 1637-1645
25. Uzabakiliho B., Largeau C., and Casadevall E. Latex constituents of Euphorbia candelabrum, E. Grantii, E. tirucalli and Synadenium grantii. Phytochemistry 26 (1987) 3041-3045
26. Valadares M.C., Carrucha S.G., Accorsi W., and Queiroz M.L. Euphorbia tirucalli L. modulates myelopoiesis and enhances the resistance of tumour-bearing mice. International Immunopharmacology 6 (2006) 294-299
27. WHO, 2007. http://www.who.int/mediacentre/factsheets/fs134/en/.